Home
BlueGenes Lab

八月 2026的BlueGenes Lab市场份额分析

SCOTTSDALE, Ariz., June 16, 2025 (GLOBE NEWSWIRE) -- BlueGenes, a leading pharmacogenetics (PGX) solution, and Levrx Technology, a digital pharmacy engagement platform, have announced a strategic partnership. Together they aim to accelerate the adoption of personalized prescribing by seamlessly integrating genetic testing insights into pharmacy benefit systems.

行业: 不适用

域bluegeneslab.com

成立年份2021

员工201 - 500

年营收--

BlueGenes Lab

BlueGenes Lab（包含公司地区分支机构）

bluegeneslab.com

查看更多网站流量和参与度信息

BlueGenes Lab热门域名的总访问量

了解BlueGenes Lab市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

bluegeneslab.com4.3K

使用销售情报查看更多信息

BlueGenes Lab热门域名的平均访问时长

分析BlueGenes Lab参与度指标。

过去 3 个月的平均访问时长

子公司明细

bluegeneslab.com00:00:46

使用销售情报查看更多信息

BlueGenes Lab热门域名的平均页面浏览量

了解BlueGenes Lab如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

bluegeneslab.com2.53

使用销售情报查看更多信息

BlueGenes Lab 排名靠前的竞争对手（按域名）

似乎没有足够的数据。

无数据可显示

BlueGenes Lab 采用的主要技术

这些是排名前 BlueGenes Lab 的顶级域名所使用的网站技术（按行业分列）

付款和货币 (9)

Visa

移动设备 (3)

Meta Viewport

转化和分析 (2)

Google Analytics

电子邮件服务 (2)

G Suite

更多技术

7

查看全部

BlueGenes Lab 的新闻与信号

借助 Similarweb 销售信号提醒，每当在目标受众之中出现新的机会或威胁时，您都会收到所识别出购买信号的每日更新。

新闻Liviniti partnered with Blue Genes Lab, LLC on Aug 1st '26.Liviniti and BlueGenes collaborate for safer, more effective medication management.

新闻Blue Genes, LLC launched precision health platform on May 20th '26.SCOTTSDALE, Ariz., May 20, 2026 (GLOBE NEWSWIRE) - Tru-1 by BlueGenes today announced its official launch, introducing a new precision health platform designed to help healthcare providers, employers, and patients better understand how genetic insights can support personalized treatment and medication decisions.

新闻Blue Genes, LLC partnered with RxSense Group on Feb 23rd '26.SCOTTSDALE, Ariz., Feb. 23, 2026 (GLOBE NEWSWIRE) - Blue Genes today announced a strategic partnership with RxSense, a leading healthcare technology company delivering innovative pharmacy benefits solutions, to integrate precision medicine insights directly into pharmacy benefit workflows, making pharmacogenomics (PGx) actionable at the point of adjudication.